Clinical Trials Logo

Colonic Diseases clinical trials

View clinical trials related to Colonic Diseases.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06438068 Not yet recruiting - Clinical trials for Constipation - Functional

Influence of Modern Colon Hydrotherapy on Intestinal Transit

Start date: May 26, 2024
Phase: N/A
Study type: Interventional

A randomised and controlled trial, in which the effect of Modern Colon Hydrotherapy is evaluated in the gastrointestinal transit of subjects with functional constipation

NCT ID: NCT06435377 Not yet recruiting - Colonic Disease Clinical Trials

Efficacy, Safety and Recurrence After Cold-EMR Plus APC for Large Colonic Lesions

EMR+APC
Start date: July 1, 2024
Phase:
Study type: Observational

This prospective observational study aims to evaluate the efficacy, safety and recurrence of cold-snaring for large colonic lesions combined with argon plasma coagulation of the resection bed.

NCT ID: NCT06271538 Not yet recruiting - Clinical trials for Irritable Bowel Syndrome

Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome

Start date: May 31, 2024
Phase: Phase 4
Study type: Interventional

The objective of this randomized, double-blind, placebo-controlled study is to evaluate the effectiveness of Skal Pro in alleviating symptoms, enhancing stool consistency, improving quality of life, and addressing psychological distress in individuals diagnosed with irritable bowel syndrome (IBS), as compared to those who receive no intervention.

NCT ID: NCT05836064 Not yet recruiting - Colonic Neoplasms Clinical Trials

GastroBot: Artificial Intelligence Applied to Bowel Preparation

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

It is estimated that about 20% of colonoscopies have inadequate preparation. (5) This is associated with lengthy procedures and less detection of adenomas, reduces the screening intervals, and increases the costs and risks of complications. Several strategies have been proposed to improve the quality of bowel preparation. Mobile healthcare Apps have been developed to increase adherence to bowel preparation agents, improving the quality of bowel preparation. However, adherence to mobile healthcare Apps is also a quality criterion and a pending problem to solve with this new technology. GastroBot is a new technology based on artificial intelligence that allows, through a software bot, to carry out a personalized follow-up of the patient's bowel cleansing, advising the patient to overcome contingencies that arise with the preparation, which in other circumstances could lead to the failure of it. The primary aim of this study is to determine the improvement in bowel preparation after GastroBot assistance compared with the traditional explanation. As a secondary aim, this study also pursues to determine adenoma and polyp detection rates (ADR and PDR, respectively), bowel preparation agents' tolerance, and GastroBot functionality.

NCT ID: NCT05715905 Not yet recruiting - Colon Cancer Clinical Trials

Analyzing Clinical Trial Experiences of Colon Cancer Patients

Start date: February 2024
Phase:
Study type: Observational

Participation in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This trial will admit a wide range of data on the clinical trial experience of Colon Cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Colon Cancer patients.

NCT ID: NCT05520229 Not yet recruiting - Colon Disease Clinical Trials

The Evaluation of a Preanaesthesia Assessment Clinic

Start date: December 1, 2022
Phase:
Study type: Observational

International evidence highlights the preanaesthetic assessment clinics (PAC) as a system of benefits for both the patient and the anaesthesiologist. The system has gained global acceptance as a routine method of optimising patients' medical conditions prior to surgery and therefore minimising surgery cancellations and improving hospital efficiency. However, a systematic review found no evidence of the efficiency of (PAC) and therefore we wanted to investigate this with the use of hospitals journals.

NCT ID: NCT05512026 Not yet recruiting - Colonic Disease Clinical Trials

Performance of the Poseidon System for Fluid Management During Water-aided Colonoscopy

Start date: September 12, 2022
Phase: N/A
Study type: Interventional

To validate the performance of the Poseidon Systemâ„¢ for fluid management during water-aided endoscopic procedures in the colon.

NCT ID: NCT05391529 Not yet recruiting - Colonic Disease Clinical Trials

Patients Decision Making in Choosing Between Colonic Investigation Alternatives

Start date: May 2022
Phase:
Study type: Observational

This is a qualitative interview study to understand patients' priorities for different aspects of tests when considering a colonic investigation. Patients currently waiting for colon capsule endoscopy (CCE), and colonoscopy will be invited to take part. Semi-structured interviews will be carried out over the telephone following an interview guide. Recorded interviews will be transcribed and undergo thematic analysis. We will seek to publish the results of this study to inform future research and developments for colonic investigations.

NCT ID: NCT05249335 Not yet recruiting - Intestinal Disease Clinical Trials

Comparison for Efficacy and Safety of Bowel Preparation Between Oral Sulfate Table and 2L-polyethylene Glycol/Ascorbate in Elderly

Start date: February 2022
Phase: Phase 4
Study type: Interventional

This study compares the effectiveness and stability of intestinal tablet (OST), an oral sulfate table (OST), developed in the form of pills, with 2L-PEG/Asc for examinees aged 70 or older who are scheduled for colonoscopy.

NCT ID: NCT04794049 Not yet recruiting - Colon Disease Clinical Trials

Comparison of Oral Lactulose Versus Polyethylene Glycol for Bowel Preparation

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

Adequate quality of bowel preparation(BP) is essential for colonoscopy. Several guidelines recommend that split-dose of 4L PEG should be used as a standard regime for BP. However, the high-volume PEG caused lower compliance to the regime and increased cost. Oral lactulose is a treatment for constipation. It tastes sweet and has no obvious gastrointestinal side effects. Previous study shows 200ml lactulose oral solution plus 2L water has been proven superior BP compared to 2L PEG. However, there is a lack of research describing bowel cleansing and colonoscopy outcomes using lactulose oral solution compared with the standard split dose of 4L PEG. Here we compared the use of a lactulose oral solution (300ml+1.5 L) with a PEG formulation (2 L) for colonoscopy preparation using the following metrics: quality of cleansing, colonoscopy outcomes, patient/physician satisfaction, and patient tolerability.